Corrigendum to "Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis" [J Hepatol 71 (2019) 543-552]
- PMID: 31668671
- DOI: 10.1016/j.jhep.2019.09.013
Corrigendum to "Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis" [J Hepatol 71 (2019) 543-552]
Erratum for
-
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis.J Hepatol. 2019 Sep;71(3):543-552. doi: 10.1016/j.jhep.2019.05.014. Epub 2019 Jun 7. J Hepatol. 2019. PMID: 31176752 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources